Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
Maini
R N
RN
Kennedy Institute of Rheumatology, London, UK.
Elliott
M J
MJ
Charles
P J
PJ
Feldmann
M
M
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D016753:Interleukin-10 / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology*; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use
D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10